Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Hendriks, L."'
Autor:
Mezquita L; Cancer Medicine Department, Gustave Roussy, Villejuif, France; Medical Oncology Department, Hospital Clínic, Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi I Sunyer Biomedical Research Institute, Barcelona, Spain. Electronic address: https://twitter.com/LauraMezquitaMD., Preeshagul I; Department of Medicine, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center NY, USA., Auclin E; Medical and Gastrointestinal Oncology Department, Georges Pompidou Hospital, Paris, France., Saravia D; Medical Oncology Department Sylvester Comprehensive Cancer Center, University of Miami., Hendriks L; Cancer Medicine Department, Gustave Roussy, Villejuif, France; Pulmonary Diseases GROW- School for Oncology and Biology, Maastricht UMC+, Maastricht, the Netherlands., Rizvi H; Department of Medicine, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center NY, USA., Park W; Medical Oncology Department Sylvester Comprehensive Cancer Center, University of Miami., Nadal E; Medical Oncology Department, Catalan Institute of Oncology, L'Hospitalet, Barcelona Spain., Martin-Romano P; Early Drug Development Department, Gustave Roussy, Villejuif, France., Ruffinelli JC; Medical Oncology Department, Catalan Institute of Oncology, L'Hospitalet, Barcelona Spain., Ponce S; Medical Oncology Department, Hospital 12 Octubre, Madrid, Spain., Audigier-Valette C; Centre Hospitalier Sainte Musse, Pneumology Department, Toulon, France., Carnio S; Thoracic Oncology Unit, Department of Oncology, University of Turin, AOU San Luigi, Orbassano (TO) Italy., Blanc-Durand F; Cancer Medicine Department, Gustave Roussy, Villejuif, France., Bironzo P; Thoracic Oncology Unit, Department of Oncology, University of Turin, AOU San Luigi, Orbassano (TO) Italy., Tabbò F; Thoracic Oncology Unit, Department of Oncology, University of Turin, AOU San Luigi, Orbassano (TO) Italy., Reale ML; Thoracic Oncology Unit, Department of Oncology, University of Turin, AOU San Luigi, Orbassano (TO) Italy., Novello S; Thoracic Oncology Unit, Department of Oncology, University of Turin, AOU San Luigi, Orbassano (TO) Italy., Hellmann MD; Department of Medicine, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center NY, USA., Sawan P; Department of Radiology, Memorial Sloan Kettering Cancer Center NY, USA., Girshman J; Department of Radiology, Memorial Sloan Kettering Cancer Center NY, USA., Plodkowski AJ; Department of Radiology, Memorial Sloan Kettering Cancer Center NY, USA., Zalcman G; Thoracic Oncology Department, CIC1425/CLIP2 Paris-Nord, Hôpital Bichat- Claude Bernard, Paris, France., Majem M; Medical Oncology Department, Hospital San Pau, Barcelona, Spain., Charrier M; Laboratory of Immunomonitoring in Oncology, UMS3655 CNRS US 23 INSERM, Gustave Roussy, Villejuif, France., Naigeon M; Laboratory of Immunomonitoring in Oncology, UMS3655 CNRS US 23 INSERM, Gustave Roussy, Villejuif, France., Rossoni C; Department Pulmonology, Erasmus MC, Rotterdam, the Netherlands., Mariniello A; Thoracic Oncology Unit, Department of Oncology, University of Turin, AOU San Luigi, Orbassano (TO) Italy., Paz-Ares L; Medical Oncology Department, Hospital 12 Octubre, Madrid, Spain., Dingemans AM; Department Pulmonology, Erasmus MC, Rotterdam, the Netherlands., Planchard D; Cancer Medicine Department, Gustave Roussy, Villejuif, France., Cozic N; Biostatistics Unit, INSERM U1018, Villejuif, France., Cassard L; Laboratory of Immunomonitoring in Oncology, UMS3655 CNRS US 23 INSERM, Gustave Roussy, Villejuif, France., Lopes G; Medical Oncology Department Sylvester Comprehensive Cancer Center, University of Miami., Chaput N; Laboratory of Immunomonitoring in Oncology, UMS3655 CNRS US 23 INSERM, Gustave Roussy, Villejuif, France; University Paris-Saclay, School of Pharmacy, France., Arbour K; Department of Medicine, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center NY, USA., Besse B; Cancer Medicine Department, Gustave Roussy, Villejuif, France; University Paris-Saclay, School of Medicine, France. Electronic address: Benjamin.besse@gustaveroussy.fr.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Jul; Vol. 151, pp. 211-220. Date of Electronic Publication: 2021 May 19.
Autor:
Gataa I; Cancer Medicine Department, Gustave Roussy, Villejuif, France; Medical Oncology Department, Cochin Hospital, Paris, France. Electronic address: Ithar.gataa@aphp.fr., Mezquita L; Cancer Medicine Department, Gustave Roussy, Villejuif, France; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Barcelona, Spain. Electronic address: lmezquita@clinic.cat., Rossoni C; Department of Biostatistics and Epidemiology, Gustave Roussy, University Paris-Saclay, Villejuif, France; Inserm, University Paris-Saclay, Labeled Ligue Contre le Cancer, Oncostat, U1018, Villejuif, France. Electronic address: caroline.rossoni@outlook.fr., Auclin E; Medical and Thoracic Oncology Department, Hôpital Européen Georges Pompidou AP-HP, Paris, France. Electronic address: ed.auclin@gmail.com., Kossai M; Pathology Department, Gustave Roussy, Villejuif, France. Electronic address: myriamkossai@gmail.com., Aboubakar F; Cancer Medicine Department, Gustave Roussy, Villejuif, France. Electronic address: frank.aboubakar@uclouvain.be., Le Moulec S; Medical Oncology Department, Institut Bergonié, Bordeaux, France. Electronic address: sylvestre.lemoulec@gmail.com., Massé J; Pathology Department, Institut Bergonié, Bordeaux, France. Electronic address: julie.masse@cjp.fr., Masson M; Medical Oncology Department, Centre Jean Perrin, Clermont-Ferrand, France. Electronic address: morganemasson1@hotmail.fr., Radosevic-Robin N; Pathology Department, Centre Jean Perrin, Clermont-Ferrand, France. Electronic address: nina.radosevic.robin@gmail.com., Alemany P; Pathology Department, Gustave Roussy, Villejuif, France. Electronic address: pierre.alemany@yahoo.fr., Rouanne M; INSERM U1015, Gustave Roussy, Villejuif, France; Hôpital Foch, UVSQ-Université Paris-Saclay, Suresnes, France. Electronic address: mathieu.rouanne@gustaveroussy.fr., Bluthgen V; Cancer Medicine Department, Gustave Roussy, Villejuif, France. Electronic address: mvbluthgen@gmail.com., Hendriks L; Cancer Medicine Department, Gustave Roussy, Villejuif, France; Department of Pulmonary Diseases, GROW - School for Oncology and Developmental Biology, Maastricht UMC+, Maastricht, the Netherlands. Electronic address: lizza.hendriks@mumc.nl., Caramella C; Radiology Department, Gustave Roussy, Villejuif, France. Electronic address: Caroline.caramella@gmail.com., Gazzah A; Early Drug Development Department, Gustave Roussy, Villejuif, France. Electronic address: anas.gazzah@gustaveroussy.fr., Planchard D; Cancer Medicine Department, Gustave Roussy, Villejuif, France. Electronic address: david.planchard@gustaveroussy.fr., Pignon JP; Department of Biostatistics and Epidemiology, Gustave Roussy, University Paris-Saclay, Villejuif, France; Inserm, University Paris-Saclay, Labeled Ligue Contre le Cancer, Oncostat, U1018, Villejuif, France. Electronic address: Jean-pierre.PIGNON@gustaveroussy.fr., Besse B; Cancer Medicine Department, Gustave Roussy, Villejuif, France; Paris-Saclay University, Faculty of Medicine, Le Kremlin, Bicêtre, France. Electronic address: benjamin.besse@gustaveroussy.fr., Adam J; Pathology Department, Gustave Roussy, Villejuif, France. Electronic address: julien.adam@gustaveroussy.fr.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Mar; Vol. 145, pp. 221-229. Date of Electronic Publication: 2021 Jan 27.
Autor:
Smit HJM; Department of Pulmonary Diseases, Rijnstate Hospital, Arnhem, the Netherlands., Aerts J; Department of Pulmonary Diseases, Erasmus Medical Center, Rotterdam, the Netherlands., van den Heuvel M; Department of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, the Netherlands., Hiltermann TJN; Department of Pulmonary Diseases, University of Groningen and University Medical Center Groningen, Groningen, the Netherlands., Bahce I; Department of Pulmonary Diseases, Amsterdam University Medical Center, Amsterdam, the Netherlands., Smit EF; Department of Thoracic Oncology, Antoni Van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Dingemans AC; Department of Pulmonary Diseases, University Medical Center Maastricht, Maastricht, the Netherlands., Hendriks LE; Department of Pulmonary Diseases, University Medical Center Maastricht, Maastricht, the Netherlands., Stigt JA; Department of Pulmonary Diseases, Isala Hospital, Zwolle, the Netherlands., Schramel FMNH; Department of Pulmonary Diseases, St. Antonius Hospital, Nieuwegein, the Netherlands., van Tinteren H; Department of Thoracic Oncology, Antoni Van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Groen HJM; Department of Pulmonary Diseases, University of Groningen and University Medical Center Groningen, Groningen, the Netherlands. Electronic address: h.j.m.groen@umcg.nl.
Publikováno v:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2020 Feb; Vol. 140, pp. 107-112. Date of Electronic Publication: 2019 Dec 28.
Autor:
Remon J; Centro Integral Oncología Clara Campal Bacelona, HM-Delfos, Medical Oncology Department, Barcelona, Spain. Electronic address: jordi.remon@delfos.cat., Hendriks LE; Gustave Roussy, Cancer Medicine Department, Villejuif, France; Maastricht University Medical Center+, Pulmonary Diseases Department, GROW - School for Oncology and Developmental Biology, Maastricht, the Netherlands. Electronic address: Lizza.HENDRIKS@gustaveroussy.fr., Cabrera C; Hospital Clínic i Provincial de Barcelona, Medical Oncology Department, Barcelona, Spain. Electronic address: Cabrera@clinic.cat., Reguart N; Hospital Clínic i Provincial de Barcelona, Medical Oncology Department, Barcelona, Spain. Electronic address: nreguart@clinic.cat., Besse B; Gustave Roussy, Cancer Medicine Department, Villejuif, France; University Paris-Sud, Orsay, France. Electronic address: Benjamin.BESSE@gustaveroussy.fr.
Publikováno v:
Cancer treatment reviews [Cancer Treat Rev] 2018 Dec; Vol. 71, pp. 47-58. Date of Electronic Publication: 2018 Oct 15.
Autor:
Hendriks L; Department of Pulmonary Diseases, †Department of Radiology, Maastricht University Medical Center+, Maastricht, The Netherlands; ‡Department of Pathology, University Hospital Antwerpen, Antwerpen, Belgium; §Department of Neurology, Maastricht University Medical Center+, Maastricht, The Netherlands; and ‖Department of Thoracic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Dingemans AM, Lammens M, Anten MM, van den Heuvel MM, Postma LA
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2015 Nov; Vol. 10 (11), pp. 1655-6.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lieverse, R., Van, L. E., Oberije, C., Troost, E. G. C., Hadrup, S., Dingemans, A., Hendriks, L., Eckert, F., Hiley, C., Dooms, C., Lievens, Y., De, J. M., Bussink, J., Geets, X., Valentini, V., Elia, G., Nerio, D., Billiet, C., Abdollahi, A., Pasquier, D., Boisselier, P., Yaromina, A., De, R. D., Dubois, L., Lambin, P.
Publikováno v:
BMC Cancer 20(2020), 557
About 50% of non-small cell lung cancer (NSCLC) patients have metastatic disease at initial diagnosis, which limits their treatment options and, consequently, the 5-year survival rate (15%). Immune checkpoint inhibitors (ICI), either alone or in comb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4577::60d7a16de35d44104c98d85c9922e05a
https://www.hzdr.de/publications/Publ-31064-1
https://www.hzdr.de/publications/Publ-31064-1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.